Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Accelerated wound healing by in vivo application of keratinocytes overexpressing KGF.

Kopp J, Wang GY, Kulmburg P, Schultze-Mosgau S, Huan JN, Ying K, Seyhan H, Jeschke MD, Kneser U, Bach AD, Ge SD, Dooley S, Horch RE.

Mol Ther. 2004 Jul;10(1):86-96.

2.

[Continuous delivery of epidermal growth factor to wounds in vivo by genetically modified fibroblasts transfected with a novel chimeric construct].

Cao L, Rosenthal F, Jiao XY, Tanczos E, Mertelsmann R, Stark GB, Kulmburg P.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 1999 Sep;13(5):263-9. Chinese.

PMID:
12080815
3.

Production of stem-cell transplants according to good manufacturing practice.

Bosse R, Kulmburg P, von Kalle C, Engelhardt M, Dwenger A, Rosenthal F, Schulz G.

Ann Hematol. 2000 Sep;79(9):469-76. Review.

PMID:
11043417
4.

Cytokine gene transfer in cancer therapy.

Cao L, Kulmburg P, Veelken H, Mackensen A, Mézes B, Lindemann A, Mertelsmann R, Rosenthal FM.

Stem Cells. 1998;16 Suppl 1:251-60. Review.

5.

Pro-inflammatory and T cell inhibitory cytokines are secreted at high levels in tumor cell cultures of human renal cell carcinoma.

Lahn M, Fisch P, Köhler G, Kunzmann R, Hentrich I, Jesuiter H, Behringer D, Muschal B, Veelken H, Kulmburg P, Iklé DN, Lindemann A.

Eur Urol. 1999 Jan;35(1):70-80.

PMID:
9933797
6.

Enhancement of a constitutively active promoter for gene therapy by a positive feed-back transcriptional activator mechanism.

Veelken H, Leutgeb B, Kulmburg P, Fiebig HH, Mackensen A, Lindemann A.

Int J Mol Med. 1998 Oct;2(4):423-8.

PMID:
9857228
7.

Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.

Prévost-Blondel A, Zimmermann C, Stemmer C, Kulmburg P, Rosenthal FM, Pircher H.

J Immunol. 1998 Sep 1;161(5):2187-94.

8.
9.

Cloning and sequence analysis of the immediate promoter region and cDNA of porcine granulocyte colony-stimulating factor.

Kulmburg P, Radke M, Mezes B, Mertelsmann R, Rosenthal FM.

Gene. 1997 Sep 15;197(1-2):361-5.

PMID:
9332386
10.

Comparison of cytogenetics, cytokine secretion, and oncogene expression in primary cultures of renal carcinoma cells.

Lahn M, Kunzmann R, Köhler G, Iklé DN, Hentrich I, Jesuiter H, Kulmburg P, Veelken H, Mackensen A, Rosenthal F, Lindemann A.

Oncology. 1997 Sep-Oct;54(5):429-37.

PMID:
9260606
11.
12.

Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts.

Mackensen A, Veelken H, Lahn M, Wittnebel S, Becker D, Köhler G, Kulmburg P, Brennscheidt U, Rosenthal F, Franke B, Mertelsmann R, Lindemann A.

J Mol Med (Berl). 1997 Apr;75(4):290-6.

PMID:
9151215
13.

NTS influence on transgene expression from mono- and bicistronic plasmid vectors after lipofection in a human fibroblast cell line.

Kulmburg P, Veelken H, Schmoor C, Rosenthal FM, Mackensen A, Lindemann A, Mertelsmann R.

J Mol Med (Berl). 1997 Mar;75(3):223-9.

PMID:
9106079
14.

A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer.

Veelken H, Mackensen A, Lahn M, Köhler G, Becker D, Franke B, Brennscheidt U, Kulmburg P, Rosenthal FM, Keller H, Hasse J, Schultze-Seemann W, Farthmann EH, Mertelsmann R, Lindemann A.

Int J Cancer. 1997 Jan 27;70(3):269-77.

15.

Processing of tumor tissues for vaccination with autologous tumor cells.

Lahn M, Köhler G, Schmoor C, Dengler W, Veelken H, Brennscheidt U, Mackensen A, Kulmburg P, Hentrich I, Jesuiter H, Rosenthal FM, Fiebig HH, Sommerkamp H, Farthmann EH, Hasse J, Mertelsmann R, Lindemann.

Eur Surg Res. 1997;29(4):292-302.

PMID:
9257102
16.

Systemic hematological effects of granulocyte colony-stimulating factor produced by irradiated gene-transfected fibroblasts.

Rosenthal FM, Kulmburg P, Früh R, Pfeifer C, Veelken H, Mackensen A, Köhler G, Lindemann A, Mertelsmann R.

Hum Gene Ther. 1996 Nov 10;7(17):2147-56.

PMID:
8934228
17.

Systematic evaluation of chimeric marker genes on dicistronic transcription units for regulated expression of transgenes in vitro and in vivo.

Veelken H, Re D, Kulmburg P, Rosenthal FM, Mackensen A, Mertelsmann R, Lindemann A.

Hum Gene Ther. 1996 Oct 1;7(15):1827-36.

PMID:
8894674
18.

In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC-positive Langerhans cell and the interdigitating dendritic cell type.

Herbst B, Köhler G, Mackensen A, Veelken H, Kulmburg P, Rosenthal FM, Schaefer HE, Mertelsmann R, Fisch P, Lindemann A.

Blood. 1996 Oct 1;88(7):2541-8.

PMID:
8839846
19.

Delineation of the dendritic cell lineage by generating large numbers of Birbeck granule-positive Langerhans cells from human peripheral blood progenitor cells in vitro.

Mackensen A, Herbst B, Köhler G, Wolff-Vorbeck G, Rosenthal FM, Veelken H, Kulmburg P, Schaefer HE, Mertelsmann R, Lindemann A.

Blood. 1995 Oct 1;86(7):2699-707.

PMID:
7545468
20.

The nomenclature of chemokines.

Prieschl EE, Kulmburg PA, Baumruker T.

Int Arch Allergy Immunol. 1995 Aug;107(4):475-83. Review.

PMID:
7620363
21.

Pilot study for the evaluation of T-cell-mediated tumor immunotherapy by cytokine gene transfer in patients with malignant tumors.

Mertelsmann R, Lindemann A, Boehm T, Brennscheidt U, Franke B, Kulmburg P, Lahn M, Mackensen A, Rosenthal FM, Veelken H.

J Mol Med (Berl). 1995 Apr;73(4):205-6. No abstract available.

PMID:
7627641
22.

A transcription factor with AP3-like binding specificity mediates gene regulation after an allergic triggering with IgE and Ag in mouse mast cells.

Jarmin DI, Kulmburg PA, Huber NE, Baumann G, Prieschl-Strassmayr EE, Baumruker T.

J Immunol. 1994 Dec 15;153(12):5720-9.

PMID:
7989769
23.

Cytokine therapy with gene-transfected cells: single injection of irradiated granulocyte-macrophage colony-stimulating factor-transduced cells accelerates hematopoietic recovery after cytotoxic chemotherapy in mice.

Rosenthal FM, Früh R, Henschler R, Veelken H, Kulmburg P, Mackensen A, Gansbacher B, Mertelsmann R, Lindemann A.

Blood. 1994 Nov 1;84(9):2960-5.

PMID:
7949168
24.

Primary fibroblasts from human adults as target cells for ex vivo transfection and gene therapy.

Veelken H, Jesuiter H, Mackensen A, Kulmburg P, Schultze J, Rosenthal F, Mertelsmann R, Lindemann A.

Hum Gene Ther. 1994 Oct;5(10):1203-10.

PMID:
7849093
25.

Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2.

Lindemann A, Brossart P, Höffken K, Flasshove M, Voliotis D, Diehl V, Kulmburg P, Wagner H, Mertelsmann R.

J Immunother Emphasis Tumor Immunol. 1994 Apr;15(3):225-30.

PMID:
8032546
26.
27.

Immunoglobulin E plus antigen challenge induces a novel intercrine/chemokine in mouse mast cells.

Kulmburg PA, Huber NE, Scheer BJ, Wrann M, Baumruker T.

J Exp Med. 1992 Dec 1;176(6):1773-8.

28.

Specific binding sites for the activator protein, ALCR, in the alcA promoter of the ethanol regulon of Aspergillus nidulans.

Kulmburg P, Judewicz N, Mathieu M, Lenouvel F, Sequeval D, Felenbok B.

J Biol Chem. 1992 Oct 15;267(29):21146-53.

29.

Identification of the promoter region involved in the autoregulation of the transcriptional activator ALCR in Aspergillus nidulans.

Kulmburg P, Sequeval D, Lenouvel F, Mathieu M, Felenbok B.

Mol Cell Biol. 1992 May;12(5):1932-9.

30.

Correct intron splicing generates a new type of a putative zinc-binding domain in a transcriptional activator of Aspergillus nidulans.

Kulmburg P, Prangé T, Mathieu M, Sequeval D, Scazzocchio C, Felenbok B.

FEBS Lett. 1991 Mar 11;280(1):11-6. Erratum in: FEBS Lett 1991 May 20;283(1):166.

Supplemental Content

Loading ...
Support Center